Millions of dollars pumped into US biodefense research has allowed researchers
to make tremendous progress toward developing countermeasures for bioterrorism,
according to a new report issued on September 29 by NIAID.
Since February 2002, NIAID has spurred researchers in government, academia,
and industry to develop vaccines, treatments, and diagnostics for bioterrorism
agents. Now, said NIAID Director Anthony Fauci, MD, officials and scientists
"are better prepared to protect citizens against deliberately introduced pathogens"
and are continuing to learn more about naturally occurring emerging infections,
such as severe acute respiratory syndrome.
Hampton T. Biodefense Research. JAMA. 2003;290(16):2117. doi:10.1001/jama.290.16.2117-a
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: